New prognostic indexes for overall survival in malignant mesothelioma treated with pemetrexed or best supportive care in the real world

Trial Profile

New prognostic indexes for overall survival in malignant mesothelioma treated with pemetrexed or best supportive care in the real world

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2015

At a glance

  • Drugs Pemetrexed (Primary)
  • Indications Mesothelioma
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 13 Apr 2015 Status changed from recruiting to completed as reported by UMIN.
    • 15 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top